» Articles » PMID: 37679541

Genotoxic Effects of Base and Prime Editing in Human Hematopoietic Stem Cells

Abstract

Base and prime editors (BEs and PEs) may provide more precise genetic engineering than nuclease-based approaches because they bypass the dependence on DNA double-strand breaks. However, little is known about their cellular responses and genotoxicity. Here, we compared state-of-the-art BEs and PEs and Cas9 in human hematopoietic stem and progenitor cells with respect to editing efficiency, cytotoxicity, transcriptomic changes and on-target and genome-wide genotoxicity. BEs and PEs induced detrimental transcriptional responses that reduced editing efficiency and hematopoietic repopulation in xenotransplants and also generated DNA double-strand breaks and genotoxic byproducts, including deletions and translocations, at a lower frequency than Cas9. These effects were strongest for cytidine BEs due to suboptimal inhibition of base excision repair and were mitigated by tailoring delivery timing and editor expression through optimized mRNA design. However, BEs altered the mutational landscape of hematopoietic stem and progenitor cells across the genome by increasing the load and relative proportions of nucleotide variants. These findings raise concerns about the genotoxicity of BEs and PEs and warrant further investigation in view of their clinical application.

Citing Articles

Multiplexed base editing identifies functional gene-variant-context interactions.

Acosta J, Johnson G, Gould S, Dong K, Lendner Y, Detres D bioRxiv. 2025; .

PMID: 40060482 PMC: 11888363. DOI: 10.1101/2025.02.23.639770.


Developing safe and efficient CGBE editor based on Cas-embedding strategy.

Lin T, Wang X, Zhang Y, Li G, Huang X, Shi M Synth Syst Biotechnol. 2025; 10(2):504-510.

PMID: 40027845 PMC: 11872432. DOI: 10.1016/j.synbio.2025.02.001.


Risk Prediction of RNA Off-Targets of CRISPR Base Editors in Tissue-Specific Transcriptomes Using Language Models.

Nakamae K, Suzuki T, Yonezawa S, Yamamoto K, Kakuzaki T, Ono H Int J Mol Sci. 2025; 26(4).

PMID: 40004186 PMC: 11855689. DOI: 10.3390/ijms26041723.


Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group.

Cavazza A, Molina-Estevez F, Plaza Reyes A, Ronco V, Naseem A, Malensek S Mol Ther Nucleic Acids. 2025; 36(1):102457.

PMID: 39991472 PMC: 11847086. DOI: 10.1016/j.omtn.2025.102457.


The reverse transcriptase domain of prime editors contributes to DNA repair in mammalian cells.

Zheng C, Zhang G, Dean L, Sontheimer E, Xue W Nat Biotechnol. 2025; .

PMID: 39962280 DOI: 10.1038/s41587-025-02568-1.


References
1.
Zeng J, Wu Y, Ren C, Bonanno J, Shen A, Shea D . Therapeutic base editing of human hematopoietic stem cells. Nat Med. 2020; 26(4):535-541. PMC: 7869435. DOI: 10.1038/s41591-020-0790-y. View

2.
Schanz S, Castor D, Fischer F, Jiricny J . Interference of mismatch and base excision repair during the processing of adjacent U/G mispairs may play a key role in somatic hypermutation. Proc Natl Acad Sci U S A. 2009; 106(14):5593-8. PMC: 2659717. DOI: 10.1073/pnas.0901726106. View

3.
Brinkman E, Chen T, Amendola M, van Steensel B . Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 2014; 42(22):e168. PMC: 4267669. DOI: 10.1093/nar/gku936. View

4.
Schiroli G, Conti A, Ferrari S, Della Volpe L, Jacob A, Albano L . Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response. Cell Stem Cell. 2019; 24(4):551-565.e8. PMC: 6458988. DOI: 10.1016/j.stem.2019.02.019. View

5.
Porteus M . A New Class of Medicines through DNA Editing. N Engl J Med. 2019; 380(10):947-959. DOI: 10.1056/NEJMra1800729. View